UFP Technologies (UFPT) is back in focus after reporting second quarter 2026 results, with revenue of US$173.96 million and net income of US$20.85 million from continuing operations.
See our latest analysis for UFP Technologies.
The strong Q2 surprise has coincided with very sharp share price momentum, with UFP Technologies posting a 1 day share price return of 25.37% and a 90 day share price return of 53.72%. The 5 year total shareholder return of 426.55% highlights how long term investors have been rewarded.
If you want to see what other stocks are moving after solid earnings updates, it could be a good time to scan 41 healthcare AI stocks
After a move like this, some investors will feel most of the gains in UFP Technologies are already on the table. Others see the recent beat as the start of a reset in what the stock is worth.
With UFP Technologies last closing at $335.41, the stock is described as trading at an 8.4% discount to an estimated fair value, yet it carries a P/E of 30.2x. That sets up an interesting mix of value signals for anyone weighing the recent share price strength against the longer term picture.
The P/E multiple compares the current share price to earnings per share, so a P/E of 30.2x means investors are paying a little over 30 times recent earnings for UFP Technologies. For a medical equipment related company, this often reflects expectations for sustained profitability and earnings growth rather than near term trading momentum alone.
Here the signals point in different directions. On one hand, UFP Technologies is described as good value compared with an internal fair value estimate and is also judged to be attractive against a peer average P/E of 50.2x. On the other hand, the company is flagged as expensive relative to an estimated fair P/E of 24x and slightly expensive versus the broader US Medical Equipment industry average of 29x. This suggests some compression toward that fair ratio level is also a possibility investors will think about. Result: Price-to-Earnings of 30.2x (ABOUT RIGHT)
Explore the SWS fair ratio for UFP Technologies
However, investors in UFP Technologies also need to weigh risks such as execution across its diverse end markets, as well as any reset in market expectations after recent share gains.
Find out about the key risks to this UFP Technologies narrative.
The picture shifts once the SWS DCF model is brought in. On this view, UFP Technologies is described as trading below an estimated future cash flow value of $292.16 when last assessed at $267.53. That points to some past pricing that was framed as undervalued. The question is whether the recent jump has already used up that gap.
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out UFP Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 53 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
With both risks and rewards in play for UFP Technologies after this sharp move, it makes sense to move quickly and review the underlying data yourself. To see a balanced snapshot of what is concerning some investors and what is attracting others, start with the 3 key rewards and 1 important warning sign.
Do not stop with UFP Technologies if you want a stronger watchlist. Use the Simply Wall St screener to uncover other stocks that suit your style.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com